Cargando…

Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data

BACKGROUND: The objectives of this study were to assess the maintenance of effect of duloxetine 60 mg once-daily (QD) in Chinese patients with chronic pain due to osteoarthritis (OA) of the knee or hip and to provide additional long-term safety data. METHODS: This was an open-label, extension phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guochun, Bi, Liqi, Li, Xiangpei, Li, Zhijun, Zhao, Dongbao, Chen, Jinwei, He, Dongyi, Wang, Chia-Ning, Wu, Tao, Dueñas, Héctor, Skljarevski, Vladimir, Yue, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477726/ https://www.ncbi.nlm.nih.gov/pubmed/31010413 http://dx.doi.org/10.1186/s12891-019-2527-y

Ejemplares similares

Clinical meaningfulness of duloxetine’s effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial
por: Yue, Li, et al.
Publicado: (2019)

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Efficacy of Duloxetine in Patients with Chronic Pain Conditions
por: Skljarevski, Vladimir, et al.
Publicado: (2011)

Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo
por: Gao, Y, et al.
Publicado: (2015)

Duloxetine use in chronic painful conditions – individual patient data responder analysis
por: Moore, RA, et al.
Publicado: (2014)

Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis
por: Li, Hu, et al.
Publicado: (2014)

Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
por: Uchio, Yuji, et al.
Publicado: (2018)

Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial
por: Zhao, Dongbao, et al.
Publicado: (2021)

The Effectiveness of Duloxetine for Knee Osteoarthritis: An Overview of Systematic Reviews
por: Zhou, Qinxin, et al.
Publicado: (2022)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
por: Dougherty, Darin D., et al.
Publicado: (2015)

Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors
por: Sheehan, David V., et al.
Publicado: (2016)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
por: Osani, Mikala C., et al.
Publicado: (2019)

An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain
por: Chen, Bo, et al.
Publicado: (2021)

The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis
por: Gao, Shi-Hua, et al.
Publicado: (2019)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Comparative efficacy of treatments for patients with knee osteoarthritis: a network meta-analysis
por: Li, Bingtong, et al.
Publicado: (2020)

Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA – a pragmatic enriched randomized controlled trial
por: Blikman, T., et al.
Publicado: (2022)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

Duloxetine hydrochloride
por: Bhadbhade, Mohan, et al.
Publicado: (2009)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
por: Nagao, Kei, et al.
Publicado: (2013)

The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis
por: Sofat, Nidhi, et al.
Publicado: (2017)

A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis
por: Ammitzbøll, Nadia, et al.
Publicado: (2021)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
por: Hong, Jihyung, et al.
Publicado: (2015)

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study
por: Yasuda, Hitoshi, et al.
Publicado: (2015)

Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009)

Dysosmia and dysgeusia associated with duloxetine
por: Yoshida, Katsuyuki, et al.
Publicado: (2017)

The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis [Corrigendum]
Publicado: (2017)

Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study
por: Li, Huafang, et al.
Publicado: (2013)

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models
por: Xu, Yong, et al.
Publicado: (2017)

The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
por: Yue, Li, et al.
Publicado: (2019)

No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial
por: van den Driest, Jacoline J., et al.
Publicado: (2022)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study
por: Yang, Yue, et al.
Publicado: (2021)

Serotonin Syndrome From Duloxetine Monotherapy: A Case Report
por: Li, Liumin, et al.
Publicado: (2023)

Duloxetine in the treatment of stress urinary incontinence
por: Jost, Wolfgang H, et al.
Publicado: (2005)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_g19skc5hud22judtei170h6im9